title: Is transdermal menopausal hormone therapy (MHT) associated with an increased cardiovascular risk?
authors.affiliation: Department of Obstetrics and Gynecology, University of Bern, Bern, Switzerland, petra.stute@insel.ch.
authors.forename: Petra
authors.initials: P
authors.lastname: Stute
mesh_terms: D000279:Administration, Cutaneous; D000368:Aged; D003327:Coronary Disease / Q000453:epidemiology*; D004305:Dose-Response Relationship, Drug; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000008:administration & dosage; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000453:epidemiology*; D011372:Progestins / Q000008:administration & dosage; D016016:Proportional Hazards Models; D011446:Prospective Studies; D012307:Risk Factors; D020521:Stroke / Q000453:epidemiology*; D014481:United States / Q000453:epidemiology
chemical_list: D004967:Estrogens; D004966:Estrogens, Conjugated (USP); D011372:Progestins